FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in its Charter) |
|
| |||
(State or Other Jurisdiction of Incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
(Address of Principal Executive Office) (Zip Code)
(
Registrant's telephone number, including area code:
N/A
(former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
Item 5.02. Appointments of Mr. Mark Frissora to Board of Directors and Mr. Reed Harris to Advisory Board
On February 3, 2025 , the Company appointed Mr. Mark Frissora to its Board of Directors. A press release was issued to this effect, which is incorporated by reference to 99.1a to this Current Report on Form 8-K.
On February 6, 2025, the Company appointed Mr. Reed Harris to its Advisory Board. A press release was issued to this effect, which is incorporated by reference to 99.1b to this Current Report on Form 8K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number |
| Exhibit Description |
|
|
|
| ||
|
|
|
|
2 |
SIGNATURE
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
February 7, 2025. | BioAdaptives, Inc. | |
/s/ James Keener | ||
| James Keener, CEO |
3 |